Brief: Xilio Therapeutics On Sept 10, Got Deficiency Letter From Nasdaq That Co Was Not In Compliance With Minimum Bid Requirement
13/09/2024 23:00
Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS: ON SEPT 10, GOT DEFICIENCY LETTER FROM
NASDAQ THAT CO WAS NOT IN COMPLIANCE WITH MINIMUM BID
REQUIREMENT
Source text for Eikon: ID:n0001558370-24-012775
Further company coverage: XLO.O
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla